This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: Facebook, United Therapeutics Surge, Micron Falls

NEW YORK ( TheStreet) --  Facebook  (FB) was jumping 3.7% to $57.13 after estimates and price target were raised by Cantor Fitzgerald. Shares are expected to reach $65 within 12 months, Cantor said. the shares are rated a buy.

Blackberry (BBRY - Get Report) was falling 0.7% to $7.17 as the shares were downgraded at Hudson Square to sell from hold. $5 price target. Service revenue is falling and the company continues to burn cash, Hudson Square said.

Salesforce.com (CRM - Get Report) was rising 1% to $54.24 as coverage of the stock was initiated with an outperform rating at BMO Capital. $62 price target. Company is positioned well for long-term growth, BMO Capital said.

Darling (DAR) was adding 1% to $20.75 as the shares were upgraded at BMO Capital to outperform. New analyst has a $25 price target. Acquisitions and JV should drive earnings growth, BMO Capital said.

[Read: Three Hits and Misses for 2014]

Five Below (FIVE) was jumping 3.7% to $44.30 as the shares were upgraded at Credit Suisse to outperform from neutral. $52 price target. Increasingly compelled by the combination of dollar store attributes and specialty retailer disciplines.

Fortinet (FTNT) was advancing 2.7% to $18.92 after being upgraded at Robert Baird to outperform from neutral. $25 price target. New CFO is a positive catalyst and the company should benefit from better security spending, Robert Baird said.

Micron (MU) was falling 3.7% to $21.35 after shares were downgraded at Bank of America/Merrill Lynch to underperform. $19.50 price target. Consensus earnings expectations appear too high, BofA/Merrill said.

United Therapeutics (UTHR) was surging 24% to $108.48 on an upgraded by J.P. Morgan to neutral. $90 price target. FDA approval for Orenitram was a surprise, J.P. Morgan said.

Xilinx (XLNX) added 0.4% to $44.89 after shares were upgraded at Drexel Hamilton to buy from hold. $50 price target. China 4G buildout gaining momentum, Drexel Hamilton said.

[Read: Alaska Air Gets Quarterback, Ratings Upgrade]

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
BBRY $10.16 0.00%
CRM $71.60 0.00%
AAPL $128.70 0.00%
FB $78.81 0.00%
GOOG $540.78 0.00%

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs